Search

Your search keyword '"Bejan-Angoulvant, T."' showing total 238 results
Start Over Author "Bejan-Angoulvant, T."
238 results on '"Bejan-Angoulvant, T."'

12. Les auteurs

Author

Bellien, J., primary, Cracowski, J.-L., additional, Ambrosi, P., additional, Andréjak, M., additional, Angoulvant, D., additional, Atkinson, C., additional, Barau, C., additional, Bedouch, P., additional, Bejan-Angoulvant, T., additional, Bellien, J., additional, Benevent, J., additional, Berreni, A., additional, Berthat, V., additional, Bourgeois, A.-L., additional, Bousquet, P., additional, Boutouyrie, P., additional, Bricca†, G., additional, Chaumais, M.-C., additional, Despas, F., additional, Donazzolo, Y., additional, Faure, S., additional, Funck-Bretano, C., additional, Gueyffier, F., additional, Ghaleh, B., additional, Lamoureux, F., additional, Laporte, S., additional, Laviolle, B., additional, Legeay, S., additional, Lotiron, C., additional, Michel, V., additional, Mismetti, P., additional, Molimard, M., additional, Monassier, L., additional, Montani, D., additional, Muller, B., additional, Pathak, A., additional, Picard, N., additional, Plotkine, M., additional, Pons, S., additional, Ribuot, C., additional, Richard, V., additional, Roustit, M., additional, Senard, J.-M., additional, Ternant, D., additional, and Timour, Q., additional

Published
2016
Full Text
View/download PDF

13. EurOP2E – the European open platform for prescribing education, a consensus study among clinical pharmacology and therapeutics teachers

Author

Bakkum, Michiel J., Richir, Milan C., Papaioannidou, Paraskevi, Likic, Robert, Sanz, Emilio J., Christiaens, Thierry, Costa, João N., Maciulaitis, Romaldas, Dima, Lorena, Coleman, Jamie, Tichelaar, Jelle, van Agtmael, Michiel A., Atanasova, Ivanka, Ganeva, Maria, Gatchev, Emil, Kostadinova, I.I., Matanovic, S. Mimica, Vitezic, D., Wozniak, Greta, Kmonickova, E., Urbanek, Karel, Damkier, P., Huupponen, R. K., Auffret, Marine, Bejan-Angoulvant, T., Chouchana, Laurent, Cracowski, Jean-Luc, Drici, M. D., Faillie, J. L., Geniaux, Hélène, Molimard, M., Orlikowski, D., Palin, Karine, Pers, Y-M, Picard, Nicolas, Simon, N., Toussirot, E., Boger, R. H., Cascorbi, I., Mueller, S. C., Regenthal, R., Schwab, M., Schwaninger, M. S., Thuermann, P. A., Wojnowski, L., Kouvelas, D., Riba, P., Kerins, David M., Williams, David J., Cosentino, M., De Ponti, Fabrizio, Filippelli, Amelia, Leone, R., Locatelli, Vittorio, Jansone, Baiba, Gulbinovic, Romaldas, Mifsud, Janet, Braszko, Jan J., Kocic, I., Breitenfeld, Luiza, Castelo-Branco, M., Conea, Simona, Magyar, Ioan, Bevc, S., Krzan, Mojca, Bernal, M. L., Capellà, D., Carcas, A., De Abajo, F. J., Lopez-Rico, M., Lucena, M. I., Pontes, C., Sanz, E. J., Böttiger, Y., Le Grevès, Madeleine, de Waard-Siebinga, I., Janssen, Ben J. A., Knol, Wilma, Pandit, Rahul, van Rosse, F., Dent, G., Ferro, Albert, Hitchings, A. W., Kapil, V., Linton, K. D., Loke, Y. K., Okorie, Michael, Plumb, Richard David, Pontefract, Sarah, Ranmuthu, S., Sampson, A. P., Thanacoody, H. K. R., Whitfield, Jonathan P., Wilson, Kurt, Bakkum M.J., Richir M.C., Papaioannidou P., Likic R., Sanz E.J., Christiaens T., Costa J.N., Maciulaitis R., Dima L., Coleman J., Tichelaar J., van Agtmael M.A., Atanasova I., Ganeva M., Gatchev E., Kostadinova I.I., Matanovic S.M., Vitezic D., Wozniak G., Kmonickova E., Urbanek K., Damkier P., Huupponen R.K., Auffret M., Bejan-Angoulvant T., Chouchana L., Cracowski J.-L., Drici M.D., Faillie J.L., Geniaux H., Molimard M., Orlikowski D., Palin K., Pers Y.-M., Picard N., Simon N., Toussirot E., Boger R.H., Cascorbi I., Mueller S.C., Regenthal R., Schwab M., Schwaninger M.S., Thuermann P.A., Wojnowski L., Kouvelas D., Riba P., Kerins D.M., Williams D.J., Cosentino M., De Ponti F., Filippelli A., Leone R., Locatelli V., Jansone B., Gulbinovic R., Mifsud J., Braszko J.J., Kocic I., Breitenfeld L., Castelo-Branco M., Conea S., Magyar I., Bevc S., Krzan M., Bernal M.L., Capella D., Carcas A., De Abajo F.J., Lopez-Rico M., Lucena M.I., Pontes C., Bottiger Y., Le Greves M., de Waard-Siebinga I., Janssen B.J.A., Knol W., Pandit R., van Rosse F., Dent G., Ferro A., Hitchings A.W., Kapil V., Linton K.D., Loke Y.K., Okorie M., Plumb R.D., Pontefract S., Ranmuthu S., Sampson A.P., Thanacoody H.K.R., Whitfield J.P., Wilson K., Internal medicine, Other Research, CCA - Cancer Treatment and quality of life, Bakkum, M, Richir, M, Papaioannidou, P, Likic, R, Sanz, E, Christiaens, T, Costa, J, Mačiulaitis, R, Dima, L, Coleman, J, Tichelaar, J, van Agtmael, M, and Locatelli, V

Subjects
Medical education, Open platform, Quality management, Pharmacoepidemiology and Prescription, Teaching Materials, media_common.quotation_subject, Language barrier, 030226 pharmacology & pharmacy, Open educational resources, law.invention, 03 medical and health sciences, 0302 clinical medicine, law, Political science, Copyright, ComputingMilieux_COMPUTERSANDEDUCATION, Humans, Pharmacology (medical), Quality (business), Cooperative Behavior, Adaptation (computer science), Schools, Medical, media_common, Pharmacology, Clinical pharmacology, 05 social sciences, Open educational resource, 050301 education, General Medicine, Quality Improvement, Clinical pharmacology and therapeutic, Europe, Digital education, Educational resources, Pharmacology, Clinical, clinical pharmacology and therapeutics, digital education, medical education, open educational resources, 0503 education, Clinical pharmacology and therapeutics, Human
Abstract

Purpose Sharing and developing digital educational resources and open educational resources has been proposed as a way to harmonize and improve clinical pharmacology and therapeutics (CPT) education in European medical schools. Previous research, however, has shown that there are barriers to the adoption and implementation of open educational resources. The aim of this study was to determine perceived opportunities and barriers to the use and creation of open educational resources among European CPT teachers and possible solutions for these barriers. Methods CPT teachers of British and EU medical schools completed an online survey. Opportunities and challenges were identified by thematic analyses and subsequently discussed in an international consensus meeting. Results Data from 99 CPT teachers from 95 medical schools were analysed. Thirty teachers (30.3%) shared or collaboratively produced digital educational resources. All teachers foresaw opportunities in the more active use of open educational resources, including improving the quality of their teaching. The challenges reported were language barriers, local differences, lack of time, technological issues, difficulties with quality management, and copyright restrictions. Practical solutions for these challenges were discussed and include a peer review system, clear indexing, and use of copyright licenses that permit adaptation of resources. Conclusion Key challenges to making greater use of CPT open educational resources are a limited applicability of such resources due to language and local differences and quality concerns. These challenges may be resolved by relatively simple measures, such as allowing adaptation and translation of resources and a peer review system.

Published
2021
Full Text
View/download PDF

15. Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics

Author

Bakkum, Michiel J., Tichelaar, Jelle, Papaioannidou, Paraskevi, Likic, Robert, Sanz Alvarez, Emilio J., Christiaens, Thierry, Costa, João N., Mačiulaitis, Romaldas, Dima, Lorena, Coleman, Jamie, Richir, Milan C., Agtmael, Michiel A., Atanasova, Ivanka, Ganeva, Maria, Gatchev, Emil, Kostadinova, I. I., Mimica Matanovic, S., Vitezic, D, Greta, Wozniak, Kmonickova, E., Karel, Urbanek, Damkier, P., Huupponen, R. K., Auffret, Marine, Bejan‐ Angoulvant, T., Laurent, Chouchana, Jean‐Luc, Cracowski, Drici, M. D., Faillie, J. L., Hélène, Geniaux, Molimard, M., Orlikowski, D., Palin, Karine, Pers, Y.‐M., Picard, Nicolas, Simon, N., Toussirot, E., Boger, R. H., Cascorbi, I., Mueller, S. C., Regenthal, R., Schwab, M., Schwaninger, M. S., Thuermann, P. A., Wojnowski, L., Kouvelas, D., Riba, P., Kerins, David M., Williams, David J., Cosentino, M., De Ponti, Fabrizio, Filippelli, Amelia, Leone, R., Locatelli, Vittorio, Jansone, Baiba, Gulbinovic, Romaldas, Mifsud, Janet, Braszko Jan, J., Kocic, I., Luiza, Breitenfeld, Castelo‐Branco, M., Simona, Conea, Ioan, Magyar, Bevc, S., Mojca, Krzan, Bernal, M. L., Capellà, D., Carcas, A., De Abajo, F. J., Lopez‐Rico, M., Lucena, M. I., Pontes, C., Sanz, E. J., Böttiger, Y., Le Grevès, Madeleine, Waard‐Siebinga, I., Janssen Ben, J. A., Wilma, Knol, Rahul, Pandit, Rosse, F., Dent, G., Albert, Ferro, Hitchings, A. W., Kapil, V., Linton, K. D., Loke, Y. K., Michael, Okorie, David, Plumb Richard, Pontefract, Sarah, Ranmuthu, S., Sampson, A. P., Thanacoody, H. K. R., Whitfield Jonathan, P., Wilson, Kurt, for the Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP), Bakkum, M, Tichelaar, J, Papaioannidou, P, Likic, R, Sanz Alvarez, E, Christiaens, T, Costa, J, Mačiulaitis, R, Dima, L, Coleman, J, Richir, M, van Agtmael, M, Locatelli, V, Internal medicine, Other Research, Bakkum M.J., Tichelaar J., Papaioannidou P., Likic R., Sanz Alvarez E.J., Christiaens T., Costa J.N., Maciulaitis R., Dima L., Coleman J., Richir M.C., van Agtmael M.A., Atanasova I., Ganeva M., Gatchev E., Kostadinova I.I., Mimica Matanovic S., Vitezic D., Greta W., Kmonickova E., Karel U., Damkier P., Huupponen R.K., Auffret M., Bejan-Angoulvant T., Laurent C., Jean-Luc C., Drici M.D., Faillie J.L., Helene G., Molimard M., Orlikowski D., Palin K., Pers Y.-M., Picard N., Simon N., Toussirot E., Boger R.H., Cascorbi I., Mueller S.C., Regenthal R., Schwab M., Schwaninger M.S., Thuermann P.A., Wojnowski L., Kouvelas D., Riba P., Kerins D.M., Williams D.J., Cosentino M., De Ponti F., Filippelli A., Leone R., Locatelli V., Jansone B., Gulbinovic R., Mifsud J., Braszko Jan J., Kocic I., Luiza B., Castelo-Branco M., Simona C., Ioan M., Bevc S., Mojca K., Bernal M.L., Capella D., Carcas A., De Abajo F.J., Lopez-Rico M., Lucena M.I., Pontes C., Bottiger Y., Le Greves M., de Waard-Siebinga I., Janssen Ben J.A., Wilma K., Rahul P., van Rosse F., Dent G., Albert F., Hitchings A.W., Kapil V., Linton K.D., Loke Y.K., Michael O., David P.R., Pontefract S., Ranmuthu S., Sampson A.P., Thanacoody H.K.R., Whitfield Jonathan P., and Wilson K.

Subjects
Computer-Assisted Instruction, Harmonization, 030226 pharmacology & pharmacy, law.invention, open educational resource, 03 medical and health sciences, 0302 clinical medicine, Medicaments -- Prescripció, law, clinical pharmacology and therapeutic, Humans, Learning, Pharmacology (medical), Narrative, 030212 general & internal medicine, Curriculum, Schools, Medical, Cross-Sectional Studie, Pharmacology, education, Medical education, Prescribing, clinical pharmacology and therapeutics, digital, open educational resources, Clinical pharmacology, Drugs -- Prescribing, Principal (computer security), Open educational resources, Variety (cybernetics), Cross-Sectional Studies, Pharmacology, Clinical, Psychology, Human
Abstract

CONTRIBUTORS IN THE NETWORK OF TEACHERS IN PHARMACOTHERAPY (NOTIP) (ALPHABETIZED BY COUNTRY): Atanasova, Ivanka (Sofia University St. Kliment Ohridski, Sofia, Bulgaria); Ganeva, Maria (Trakia University, Stara Zagora, Bulgaria); Gatchev, Emil (Medical University of Sofia, Sofia, Bulgaria); Kostadinova, II (Medical University Plovdiv, Plovdiv, Bulgaria); Mimica Matanovic, S (University of Osijek, Osijek, Croatia); Vitezic, D (University of Rijeka Medical School, Rijeka, Croatia); Wozniak, Greta (University of Cyprus, Nicosia, Cyprus); Kmonickova, E (Charles University, Pilsen, Czech Republic); Urbanek, Karel (Palacky University, Olomouc, Czech Republic); Damkier, P (University of Southern Denmark, Odense, Denmark); Huupponen, RK (University of Turku, Turku, Finland); Auffret, Marine (Hospices civils de Lyon, Lyon, France); Bejan-Angoulvant, T (Université de Tours, Tours, France); Chouchana, Laurent (Hospital Cochin, Paris, France); Cracowski, Jean-Luc (University Grenoble Alpes, La Tronche, France); Drici, MD (University of Nice Côte d'Azur, Nice, France); Faillie, JL (CHU Montpellier, Montpellier, France); Geniaux, Hélène (CHU de Limoges, Limoges, France); Molimard, M (Université de Bordeaux, Bordeaux, France); Orlikowski, D (Versailles Saint-Quentin-en-Yvelines University, Versailles, France); Palin, Karine (University of Bordeaux, Bordeaux, France); Pers, Y-M (CHU Montpellier, Montpellier, France); Picard, Nicolas (CHU de Limoges, Limoges, France); Simon, N (Aix-Marseille University, Marseille, France); Toussirot, E (CHU de Besancon, Besancon, France); Boger, RH (University Medical Center Hamburg-Eppendorf, Hamburg, Germany); Cascorbi, I (University of Kiel, Kiel, Germany); Mueller, SC (University Medicine Rostock, Rostock, Germany); Regenthal, R (University of Leipzig, Leipzig, Germany); Schwab, M (Eberhard Karl University of Tübingen, Tübingen, Germany); Schwaninger, MS (University of Luebeck, Luebeck, Germany); Thuermann, PA (University Witten/Herdecke, Witten, Germany); Wojnowski, L (University Medical Center Mainz, Mainz, Germany); Kouvelas, D (Aristotle University of Thessaloniki, Thessaloniki, Greece); Riba, P (Semmelweis University, Budapest, Hungary); Kerins, David M (University College, Cork, Ireland); Williams, David J (Royal College of Surgeons in Ireland, Dublin, Ireland); Cosentino, M (University of Insubria, Varese, Italy); De Ponti, Fabrizio (University of Bologna, Bologna, Italy); Filippelli, Amelia (University of Salerno, Baronissi, Italy); Leone, R (University of Verona, Verona, Italy); Locatelli, Vittorio (University of Milano - Bicocca, Monza, Italy); Jansone, Baiba (University of Latvia, Riga, Latvia); Gulbinovic, Romaldas (Vilnius University, Vilnius, Lithuania); Mifsud, Janet (University of Malta, Msida, Malta); Braszko, Jan J (Medical University of Bialystok, Bialystok, Poland); kocic, I (Medical University of Gdansk, Gdansk, Poland); Breitenfeld, Luiza (Beira Interior University, Covilh~a, Portugal); Castelo-Branco, M (University of Beira Interior, Covilh~a, Portugal); Conea, Simona (“Vasile Goldis” Western University of Arad, Arad, Romania); Magyar, Ioan (University of Oradea, Oradea, Romania); Bevc, S (University of Maribor, Maribor, Slovenia); Krzan, Mojca (University of Ljubljana, Ljubljana, Slovenia); Bernal, ML (University of Zaragoza, Zaragoza, Spain); Capellà, D (University of Girona, Girona, Spain); Carcas, A (Universidad Autónoma de Madrid, University of Maribor, Spain); De Abajo, FJ (University of Alcalá, Alcalá de Henares, Spain); Lopez-Rico, M (University of Salamanca, Salamanca, Spain); Lucena, MI (University of Malaga, Malaga, Spain); Pontes, C (Universitat Autonoma de Barcelona, Sabadell, Spain); Sanz, EJ (Universidad de La Laguna, La Laguna, Spain); Böttiger, Y (Linköping University, Linköping, Sweden); Le Grevès, Madeleine (Uppsala University, Uppsala, Sweden); de Waard-Siebinga, I (University Medical Center Groningen, Groningen, The Netherlands); Janssen, Ben JA (Maastricht University, Maastricht, The Netherlands); Knol, Wilma (University Medical Center Utrecht, Utrecht, The Netherlands); Pandit, Rahul (University Medical Center Utrecht, Utrecht, The Netherlands); van Rosse, F (Erasmus Medical Center, Rotterdam, The Netherlands); Dent, G (Keele University, Keele, United Kingdom); Ferro, Albert (King's College London, London, United Kingdom); Hitchings, AW (St George's, University of London, London, United Kingdom); Kapil, V (Queen Mary University London, London, United Kingdom); Linton, KD (University of Sheffield, Sheffield, United Kingdom); Loke, YK (University of East Anglia, Norwich, United Kingdom); Okorie, Michael (Brighton and Sussex Medical School, Brighton, United Kingdom); Plumb, Richard David (Queen's University Belfast, Belfast, United Kingdom); Pontefract, Sarah (University of Birmingham, Birmingham, United Kingdom); Ranmuthu, S (Queen Mary University London, London, United Kingdom); Sampson, AP (University of Southampton, Southampton, United Kingdom); Thanacoody, HKR (Newcastle University, Newcastle upon Tyne, United Kingdom); Whitfield, Jonathan P (University of Aberdeen, Aberdeen, United Kingdom); Wilson, Kurt (University of Manchester, Manchester, United Kingdom) Improvement and harmonization of European clinical pharmacology and therapeutics (CPT) education is urgently required. Because digital educational resources can be easily shared, adapted to local situations and re‐used widely across a variety of educational systems, they may be ideally suited for this purpose Methods With a cross‐sectional survey among principal CPT teachers in 279 out of 304 European medical schools, an overview and classification of digital resources was compiled. Results Teachers from 95 (34%) medical schools in 26 of 28 EU countries responded, 66 (70%) of whom used digital educational resources in their CPT curriculum. A total of 89 of such resources were described in detail, including e‐learning (24%), simulators to teach pharmacokinetics and/or pharmacodynamics (10%), virtual patients (8%), and serious games (5%). Together, these resources covered 235 knowledge‐based learning objectives, 88 skills, and 13 attitudes. Only one third (27) of the resources were in‐part or totally free and only two were licensed open educational resources (free to use, distribute and adapt). A narrative overview of the largest, free and most novel resources is given. Conclusion Digital educational resources, ranging from e‐learning to virtual patients and games, are widely used for CPT education in EU medical schools. Learning objectives are based largely on knowledge rather than skills or attitudes. This may be improved by including more real‐life clinical case scenarios. Moreover, the majority of resources are neither free nor open. Therefore, with a view to harmonizing international CPT education, more needs to be learned about why CPT teachers are not currently sharing their educational materials.

Published
2020
Full Text
View/download PDF

21. Info-médicaments

Author

Vrignaud, L., Simon, C., Agier, M.-S., Bejan-Angoulvant, T., Bouquet, E., Beau-Salinas, F., and Jonville-Béra, A.-P.

Published
2017
Full Text
View/download PDF

39. Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial

Author

Gueyffier, F., Subtil, F., Bejan-Angoulvant, T., Zerbib, Y., Baguet, J. P., Boivin, J. M., Mercier, A., Leftheriotis, G., Gagnol, J. P., Fauvel, J. P., Giraud, C., Bricca, G., Maucort-Boulch, Delphine, Erpeldinger, S., Biostatistiques santé, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), and Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV]Life Sciences [q-bio]
Published
2015

40. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français

Author

Marret, Henri, Simon, E, Beucher, Gael, Dreyfus, Michel, Gaudineau, Adrien, Vayssière, Christophe, Lesavre, M, Pluchon, M, Winer, Norbert, Fernandez, H, Aubert, J, Bejan Angoulvant, T, Jonville-Bera, Annie-Pierre, Clouqueur, E, Houfflin-Debarge, V, Garrigue, A, Pierre, F, Collège national des gynécologues obstétriciens français, ., Université Francois Rabelais [Tours], U930, Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hôpitaux Universitaires de Strasbourg, CHU Toulouse [Toulouse], Service Gynécologie Obstétrique, Hôpital de Bicêtre, Centre Hospitalo-Universitaire, Physiologie des Adaptations Nutritionnelles (PhAN), Institut National de la Recherche Agronomique (INRA)-Université de Nantes (UN), Centre Hospitalier Régional Universitaire de Tours (CHRU de Tours), Hôpital Jeanne de Flandre [Lille], and Centre hospitalier universitaire de Poitiers (CHU Poitiers)

Subjects
medicine.medical_specialty, medicine.medical_treatment, Elective abortion, Administration, Sublingual, Gestational Age, Hysteroscopy, [SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics, Miscarriage, 03 medical and health sciences, 0302 clinical medicine, Obstetrics and gynaecology, Pregnancy, Gemeprost, Medicine, Humans, 030212 general & internal medicine, Medically-indicated termination of pregnancy, Misoprostol, Fetal Death, Gynecology, Vacuum aspiration, Abortifacient Agents, Nonsteroidal, 030219 obstetrics & reproductive medicine, medicine.diagnostic_test, business.industry, Obstetrics, Postpartum Hemorrhage, Obstetrics and Gynecology, Gestational age, Abortion, Induced, Mifepristone, Off-Label Use, medicine.disease, 3. Good health, Administration, Intravaginal, Reproductive Medicine, Female, France, business, medicine.drug, Cervical Ripening
Abstract

The literature suggests that misoprostol can be offered to patients for off-label use as it has reasonable efficacy, risk/benefit ratio, tolerance and patient satisfaction, according to the criteria for evidence-based medicine. Both the vaginal and sublingual routes are more effective than the oral route for first-trimester cervical dilatation. Vaginal misoprostol 800 μg, repeated if necessary after 24 or 48 h, is a possible alternative for management after early pregnancy failure. However, misoprostol has not been demonstrated to be useful for the evacuation of an incomplete miscarriage, except for cervical dilatation before vacuum aspiration. Oral mifepristone 200 mg, followed 24–48 h later by vaginal, sublingual or buccal misoprostol 800 μg (followed 3–4 h later, if necessary, by misoprostol 400 μg) is a less efficacious but less aggressive alternative to vacuum aspiration for elective or medically-indicated first-trimester terminations; this alternative becomes increasingly less effective as gestational age increases. In the second trimester, vaginal misoprostol 800–2400 μg in 24 h, 24–48 h after at least 200 mg of mifepristone, is an alternative to surgery, sulprostone and gemeprost. Data for the third trimester are sparse. For women with an unripe cervix and an unscarred uterus, vaginal misoprostol 25 μg every 3–6 h is an alternative to prostaglandin E2 for cervical ripening at term for a live fetus. When oxytocin is unavailable, misoprostol can be used after delivery for prevention (sublingual misoprostol 600 μg) and treatment (sublingual misoprostol 800 μg) of postpartum haemorrhage. The use of misoprostol to promote cervical dilatation before diagnostic hysteroscopy or surgical procedures is beneficial for premenopausal women but not for postmenopausal women. Nonetheless, in view of the side effects of misoprostol, its use as a first-line treatment is not indicated, and it should be reserved for difficult cases. Misoprostol is not useful for placing or removing the types of intra-uterine devices used in Europe, regardless of parity.

Published
2014
Full Text
View/download PDF

42. Problématique des cibles de pression artérielle

Author

Boussageon, R., Bejan-Angoulvant, T., Gueyffier, François, Evaluation et modélisation des effets thérapeutiques, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), and Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV]Life Sciences [q-bio]
Published
2011

44. Info-médicaments

Author

Beau-Salinas, F., primary, Lengellé, C., additional, Bejan-Angoulvant, T., additional, and Jonville-Béra, A.-P., additional

Published
2015
Full Text
View/download PDF

47. Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?

Author

Bejan-Angoulvant, T., Bouvier, A.-M., Bossard, Nadine, Belot, A., Jooste, V., Launoy, G., Remontet, L., Evaluation et modélisation des effets thérapeutiques, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), and Biostatistiques santé

Subjects
[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]
Published
2008

48. Critique du modèle additif de l'essai clinique randomisé

Author

Boussageon, R., Gueyffier, F., Bejan-Angoulvant, T., Felden, Géraldine, Biostatistiques santé, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), and Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV]Life Sciences [q-bio]
Published
2008

Catalog

Books, media, physical & digital resources
See catalog results